8-K current report · filed Nov 2, 2026

CorMedix Inc. (CRMD) 8-K Current Report: November 2, 2026

Item 2.02Item 7.01Item EX-99.1CRMD overview

Short answer

CorMedix Inc. (CRMD) filed an 8-K current report with the SEC on November 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CorMedix announced its cash position for the quarter ended September 30, 2026.

CorMedix Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • CorMedix announced its cash position for the quarter ended September 30, 2026
  • Cash-position details and management commentary are contained in Exhibit 99.1
  • Liquidity update is material for funding ongoing operations and commercialization activities

Item 7.01 · Regulation FD Disclosure

  • Business update and cash position announcement for quarter ended September 30, 2026
  • Exhibit 99.1 contains operating details and liquidity information relevant to CorMedix’s near-term outlook
  • 2027 DefenCath TDAPA Add-on estimates depend on CMS methodology, utilization, pricing and reimbursement assumptions
  • Dialysis-facility reimbursement increases may not translate into higher CorMedix pricing, utilization or revenue

Item EX-99.1 · Exhibit EX-99.1

  • Cash and equivalents approximately $355 million as of September 30, 2026, supporting commercial expansion and near-term liquidity
  • 2026 revenue guidance reaffirmed at $325 million to $345 million, reducing risk of an in-quarter outlook cut
  • CMS set DefenCath’s Q1 2027 post-TDAPA Add-on at $8.32 per dialysis session, versus $2.37 in Q3-Q4 2026
  • Management expects 2027 Add-on rates above $2.37 every quarter, with the annual average exceeding 2x the current rate
  • Q2 2027 Add-on decline expected before recovery in Q3 and/or Q4, creating quarterly reimbursement volatility for investors

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CorMedix Inc. 8-K filings

Get the next CRMD 8-K as it lands

Follow CRMD for push alerts, or ask the research agent what this filing means.